$6.63
-0.02 (-0.30%)
Flamel Technologies S.A. (ADR) (NASDAQ:FLML)
CAPS Rating:
A biopharmaceutical company principally engaged in the development of two unique polymer-based drug delivery technologies for the improvement of medical applications.
RSS Headlines
Fool UK